secwatch.observer — SEC 8-K summary
======================================

Issuer:     Twist Bioscience Corp (TWST)
CIK:        0001581280
Form:       8-K
Filed at:   2022-10-26T23:59:59+00:00
Accession:  0001104659-22-111354
Event type: leadership
Sentiment:  positive
Materiality: 0.60
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Twist Bioscience promotes Patrick Finn to President and COO
-----------------------------------------------------------

- Patrick Finn, formerly Chief Commercial Officer, appointed President and COO effective October 25, 2022.
- Finn joined Twist in 2015 and led sales growth from $2M (FY2016) to $184M (12 months ended June 30, 2022).
- New role adds oversight of operations to commercial responsibilities.
- Compensation: base salary $470,000, 60% bonus target, $100,000 one-time cash bonus, $10K/month housing allowance, and $4.4M in RSUs. equity award.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1581280/000110465922111354/0001104659-22-111354-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1581280/000110465922111354/tm2228812d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-111354

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer